Rocket Lab SEC Filings

On April 12, 2024, board director Sven Strohband notified Rocket Lab he will not seek re-election at the 2024 Annual Meeting. The decision is unrelated to any dispute with company operations, policies, or practices. He will serve until the meeting; no financial impact disclosed.

Khosla Ventures entities (10% owners/directors via Vinod Khosla) disposed of 10,752,561 and 610,362 common shares via pro rata distributions to partners on 03/11/2024 at $0. No open market transaction occurred. Neutral signal as internal reallocation.

Sven Strohband, Director at Rocket Lab USA, acquired 59,464 shares of common stock on 03/11/2024 through a pro rata distribution from Khosla Ventures funds, held indirectly via trust. Post-transaction indirect holdings: 299,237 shares. Neutral signal as it's a non-discretionary distribution.

This SC 13D/A (Amendment No. 3) filed March 13, 2024, by Khosla Ventures entities and Vinod Khosla discloses pro rata share distributions on March 11, 2024, among affiliates. Total beneficial ownership remains 79,853,630 shares (16.3% of 489M outstanding). No sales to third parties or changes in investment intent, relevant for tracking major shareholder activity.

Adam C. Spice, Chief Financial Officer of Rocket Lab USA, sold 67,160 shares of common stock on March 5, 2024, at a weighted average price of $4.253. The sale was a sell-to-cover transaction to satisfy tax withholding obligations upon vesting of restricted stock units. This is a neutral signal as it is routine and non-discretionary.

Arjun Kampani, General Counsel at Rocket Lab USA, executed a sale of 31,394 shares on March 5, 2024. The transaction was a 'sell-to-cover' to cover tax obligations from vesting restricted stock units (RSUs). This is a neutral signal, as it is routine and non-discretionary.

Form 144 discloses Rocket Lab officer Arjun Kampani's intent to sell 31,394 common shares acquired via restricted stock vesting on 03/01/2024 as compensation. Aggregate market value is $133,515.54, with proposed sale around 03/05/2024 via Fidelity on NASDAQ. Relevant to investors as routine insider sale with no prior 3-month activity and certification of no undisclosed material adverse information.

Rocket Lab officer Adam C. Spice filed Form 144 on March 5, 2024, to sell 67,160 common shares acquired via restricted stock vesting on March 1, 2024, as compensation. The shares have an aggregate market value of $285,625, with no prior sales in the past three months. This routine insider transaction provides liquidity from equity awards but warrants monitoring for broader selling trends.

Annual Report - FY 2023

Rocket Lab reported FY2023 revenue of $244.6M, up 16% YoY from $211.0M, driven by higher launch cadence (10 missions) and space systems growth. Gross margin improved to 21% from 9%, reflecting efficiencies. Net loss widened to $182.6M from $135.9M due to R&D investments in Neutron. Backlog reached $1.05B.

Rocket Lab reported Q4 2023 financial results, highlighting a $515M Space Development Agency contract win and record launch signings. The company provided Q1 2024 revenue guidance of $92M-$98M, reflecting significant sequential growth.